General Partner Healthtech/Therapeutics - Venture&Growth
Gilde HealthcareCheck size: Gilde Healthcare does not publish one standard check-size range across its strategies on the official site.
Arthur Franken invests or supports investments through Gilde Healthcare's published strategy: Invest through specialist strategies in healthcare technology, therapeutics, care providers and climate solutions that improve health outcomes.
Experienced teams, proven or defensible innovation and clear potential to improve care, health or climate-related outcomes at scale.
Opportunities outside the firm's healthcare and climate strategy set or without specialist evidence and value creation potential are less aligned.
Identify the relevant strategy and show the need, evidence, differentiation, team, economics and milestones for investment.
No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.
No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.
Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.
Arthur Franken is a current General Partner Healthtech/Therapeutics - Venture&Growth at Gilde Healthcare, according to the firm's official roster. No additional background is inferred where the firm does not publish a biography.